Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Theriva Biologics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q3 2021
- Shares held
- 11.9M
- +4.67M (+64.5%) vs. Q3 2021
- Total value
- $3.24M
- −$83.0K (−2.5%) vs. Q3 2021
- New holders
- 6
- 13 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $366.3K |
| Q4 2023 | 24 | $452.3K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $477.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.51M |
| Q1 2022 | 35 | $3.17M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 307 | $0 | 0.00% | −426−58.1% | Reduced |
| Wells Fargo & Company | 810 | $0 | 0.00% | +1+0.1% | Added |
| BNP Paribas Arbitrage, SA | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 479 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 143 | $0 | 0.00% | 00.0% | Unchanged |
| Widmann Financial Services, Inc. | 58 | $0 | 0.00% | +58 | New |
| Leverty Financial Group, LLC | 143 | $0 | 0.00% | +143 | New |
| Manufacturers Life Insurance Company, The | 10,597 | $3.00K | 0.00% | −12,980−55.1% | Reduced |
| Creative Planning | 10,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 10,072 | $3.00K | 0.00% | +9,885+5,286.1% | Added |
| Victory Capital Management Inc | 19,016 | $5.00K | 0.00% | −592−3.0% | Reduced |
| Jacobi Capital Management LLC | 18,500 | $5.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 13,825 | $5.00K | 0.00% | +10,000+261.4% | Added |
| Buckingham Strategic Wealth, LLC | 17,500 | $5.00K | 0.00% | +17,500 | New |
| Morgan Stanley | 21,091 | $6.00K | 0.00% | +70.0% | Added |
| Renaissance Technologies LLC | 20,600 | $6.00K | 0.00% | +20,600 | New |
| Sterneck Capital Management, LLC | 25,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Landmark Financial Advisors, LLC | 24,200 | $7.00K | 0.00% | +24,200 | New |
| Tower Research Capital LLC (TRC) | 59,276 | $16.0K | 0.00% | +46,016+347.0% | Added |
| Bridgeway Capital Management, LLC | 74,300 | $20.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 84,075 | $23.0K | 0.00% | −129,000−60.5% | Reduced |
| UBS Group AG | 97,378 | $26.0K | 0.00% | +44,867+85.4% | Added |
| Fisher Asset Management, LLC | 125,698 | $34.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 164,500 | $45.0K | 0.00% | +36,200+28.2% | Added |
| Blair William & Co | 216,089 | $59.0K | 0.00% | +12,446+6.1% | Added |
| Northern Trust Corp | 245,399 | $67.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 278,026 | $76.0K | 0.00% | +234,318+536.1% | Added |
| Virtu Financial LLC | 331,543 | $90.0K | 0.01% | +139,198+72.4% | Added |
| MSD Partners, L.P. | 349,290 | $96.0K | 0.00% | +232,860+200.0% | Added |
| State Street Corp | 471,920 | $128.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 976,316 | $265.0K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 1,100,029 | $299.0K | 0.00% | +1,100,029 | New |
| BlackRock Inc. | 1,885,693 | $513.0K | 0.00% | +8,784+0.5% | Added |
| Vanguard Group Inc | 5,248,399 | $1.43M | 0.00% | +3,233,601+160.5% | Added |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −275,240−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −21,997−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Clearview Wealth Advisors LLC | 0 | $0 | 0.00% | −20,418−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,855−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |